GRPR

(redirected from Gastrin-releasing peptide receptor)
Also found in: Wikipedia.
AcronymDefinition
GRPRgastrin-releasing peptide receptor
GRPRGlass Road Public Relations
GRPRBombesin/Gastrin Releasing Peptide Receptor
GRPRGinny Richardson Public Relations
GRPRGraduate Research Progress Reports
GRPRGlobal and Regional Program Review
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Gastrin-releasing peptide receptor overall percentage and intensity of tumor cell expression staining were more pronounced in clinical stages III and IV and extensive disease compared with GRPR expression in clinical stages I and II.
Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.
Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.
Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer.
Membranous and cytoplasmic immunolocalization of gastrin-releasing peptide receptor in non-small cell lung carcinoma tissue.
Gastrin-releasing peptide receptor (GRPR) expression in males and females showing no detectable difference in GRPR expression.
Overall survival of lung cancer and gastrin-releasing peptide receptor (GRPR) expressers calculated using the Kaplan-Meier survival curves.
Gastrin-Releasing Peptide Receptor Immunohistochemical Analysis Correlating Percentage and Intensity of Tumor Cell Expression (a) % Stained Tumor Cells Cell Type Negative 1-25 1 + 2+ 3+ Adenocarcinoma (n = 100) 32 17 0 0 Squamous (n = 71) 31 7 0 0 Large cell (n = 29) 12 6 0 0 Small cell (n = 38) 18 5 0 0 % Stained Tumor Cells Cell Type 25-50 1 + 2+ 3+ Adenocarcinoma (n = 100) 12 2 0 Squamous (n = 71) 7 1 0 Large cell (n = 29) 3 1 0 Small cell (n = 38) 4 0 0 % Stained Tumor Cells Cell Type 50-100 1 + 2+ 3+ Adenocarcinoma (n = 100) 13 14 10 Squamous (n = 71) 15 7 3 Large cell (n = 29) 3 2 2 Small cell (n = 38) 5 5 1 (a) Immunostaining and measurement of stain were performed as described in "Materials and Methods." Table 2.